Groundbreaking nipocalimab study of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn published in The New England Journal of Medicine PR...
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet regimen approved in the U.S. for patients with newly diagnosed multiple myeloma who are transplant-eligible PR...
Johnson & Johnson (NYSE: JNJ) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5th, at the Encore Boston Harbor, Evertte, MA. Tim Schmid, Executive Vice...
U.S. Court of Appeals for 3rd Circuit latest to reject unprecedented bankruptcy strategy Lawyers on behalf of tens of thousands of ovarian cancer victims are calling on Johnson & Johnson...
Those Who Previously Voted “No” Can Still Switch Their Vote to “Yes” Today at 5pm ET is the final deadline for tens of thousands of ovarian cancer victims or their representatives to vote on the...
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held at the New York Marriott Marquis, New York, NY...
Beasley Allen, Levin Papantonio, and coalition of law firms cite misleading efforts to secure approval Thousands of individuals who are being told they may be eligible for quick and significant...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.